OBJECTIVE: Previous studies have established that hydrolysis of LDL by Group V secretory phospholipase A(2) (GV sPLA(2)) generates a modified particle capable of inducing macrophage foam cell formation. The aim of the present study was to determine whether GV sPLA(2)-hydrolyzed LDL (GV-LDL) produces pro-atherogenic effects in macrophages independent of cholesterol accumulation. METHODS AND RESULTS: J-774 cells incubated with GV-LDL produced more TNF-alpha and IL-6 compared to cells incubated with control-LDL. Indirect immunofluorescence showed that GV-LDL but not control-LDL induced nuclear translocation of NFkappaB. Inhibitors of NFkappaB activation, effectively blocked cytokine production induced by GV-LDL. Control-LDL and GV-LDL were separated from albumin present in reaction mixtures by ultracentrifugation. The albumin fraction derived from GV-LDL contained 80% of the FFA generated and was more potent than the re-isolated GV-LDL in inducing pro-inflammatory cytokine secretion. Linoleic acid (18:2) and oleic acid (18:1) were the most abundant FFAs generated, whereas newly formed lyso-PCs contained 14:0 (myristic), 16:1 (palmitic), and 18:2 fatty acyl groups. Experiments with synthetic FFA showed that 18:1 induced J-774 cells to secrete TNF-alpha and IL-6. CONCLUSIONS: These results indicate that in addition to promoting atherosclerotic lipid accumulation in macrophages, GV sPLA(2) hydrolysis of LDL leads to activation of NFkappaB, a key regulator of inflammation. 2010 Elsevier Ltd. All rights reserved.
OBJECTIVE: Previous studies have established that hydrolysis of LDL by Group V secretory phospholipase A(2) (GV sPLA(2)) generates a modified particle capable of inducing macrophage foam cell formation. The aim of the present study was to determine whether GV sPLA(2)-hydrolyzed LDL (GV-LDL) produces pro-atherogenic effects in macrophages independent of cholesterol accumulation. METHODS AND RESULTS:J-774 cells incubated with GV-LDL produced more TNF-alpha and IL-6 compared to cells incubated with control-LDL. Indirect immunofluorescence showed that GV-LDL but not control-LDL induced nuclear translocation of NFkappaB. Inhibitors of NFkappaB activation, effectively blocked cytokine production induced by GV-LDL. Control-LDL and GV-LDL were separated from albumin present in reaction mixtures by ultracentrifugation. The albumin fraction derived from GV-LDL contained 80% of the FFA generated and was more potent than the re-isolated GV-LDL in inducing pro-inflammatory cytokine secretion. Linoleic acid (18:2) and oleic acid (18:1) were the most abundant FFAs generated, whereas newly formed lyso-PCs contained 14:0 (myristic), 16:1 (palmitic), and 18:2 fatty acyl groups. Experiments with synthetic FFA showed that 18:1 induced J-774 cells to secrete TNF-alpha and IL-6. CONCLUSIONS: These results indicate that in addition to promoting atheroscleroticlipid accumulation in macrophages, GV sPLA(2) hydrolysis of LDL leads to activation of NFkappaB, a key regulator of inflammation. 2010 Elsevier Ltd. All rights reserved.
Authors: Ouliana Ziouzenkova; Stephane Perrey; Liana Asatryan; Juliana Hwang; Karen L MacNaul; David E Moller; Daniel J Rader; Alex Sevanian; Rudolf Zechner; Gerald Hoefler; Jorge Plutzky Journal: Proc Natl Acad Sci U S A Date: 2003-02-26 Impact factor: 11.205
Authors: Joo Y Lee; Anthony Plakidas; Won H Lee; Anne Heikkinen; Prithiva Chanmugam; George Bray; Daniel H Hwang Journal: J Lipid Res Date: 2002-12-01 Impact factor: 5.922
Authors: Michael Spencer; Brian S Finlin; Resat Unal; Beibei Zhu; Andrew J Morris; Lindsey R Shipp; Jonah Lee; R Grace Walton; Akosua Adu; Rod Erfani; Marilyn Campbell; Robert E McGehee; Charlotte A Peterson; Philip A Kern Journal: Diabetes Date: 2013-01-17 Impact factor: 9.461
Authors: Yuri V Bobryshev; Ekaterina A Ivanova; Dimitry A Chistiakov; Nikita G Nikiforov; Alexander N Orekhov Journal: Biomed Res Int Date: 2016-07-17 Impact factor: 3.411
Authors: Samuel Hernandez-Anzaldo; Vesna Brglez; Bianca Hemmeryckx; Dickson Leung; Janos G Filep; Jean E Vance; Dennis E Vance; Zamaneh Kassiri; Roger H Lijnen; Gérard Lambeau; Carlos Fernandez-Patron Journal: J Am Heart Assoc Date: 2016-09-30 Impact factor: 5.501